(Q35757560)

10 August 2017

title

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.25.3.319

10 August 2017

0 references

1 reference

3 September 2023

author name string

N. X. Chin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232895

3 September 2023

H. C. Neu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232895

3 September 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

full work available at URL

10 August 2017

https://europepmc.org/articles/PMC185508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232895

https://europepmc.org/articles/PMC185508?pdf=render

3 September 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232895

https://journals.asm.org/doi/pdf/10.1128/AAC.25.3.319

3 September 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.25.3.319

Antimicrobial Agents and Chemotherapy

3 September 2023

published in

1 reference

10 August 2017

volume

25

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

319-326

1 reference

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185508

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185508

Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185508

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185508

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185508

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6232895

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.25.3.319

1 reference

10 August 2017

1 reference

10 August 2017

1 reference